Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
IBER.U was delisted on the 1st of March, 2023.
0 hedge funds and large institutions have $0 invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 10 closing their positions.
100% less funds holding
Funds holding: 10 → 0 (-10)
100% less capital invested
Capital invested by funds: $4.01M → $0 (-$4.01M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIA
Schechter Investment Advisors
Birmingham,
Michigan
|
-$1.75M |
| 2 |
HF
HRT Financial
New York
|
-$649K |
| 3 |
Jane Street
New York
|
-$573K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$366K |
| 5 |
TAM
Terrapin Asset Management
Miami,
Florida
|
-$186K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SIA
1
Schechter Investment Advisors
Birmingham,
Michigan
| – | -$1.75M | -175,562 | Closed |
|
|
HF
2
HRT Financial
New York
| – | -$649K | -64,980 | Closed |
|
|
3
Jane Street
New York
| – | -$573K | -57,472 | Closed |
|
|
LCM
4
Landscape Capital Management
Englewood,
New Jersey
| – | -$366K | -36,568 | Closed |
|
|
TAM
5
Terrapin Asset Management
Miami,
Florida
| – | -$186K | -18,510 | Closed |
|
|
WC
6
Wealthspring Capital
West Harrison,
New York
| – | -$180K | -18,040 | Closed |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$159K | -15,899 | Closed |
|
|
SMA
8
Sage Mountain Advisors
Atlanta,
Georgia
| – | -$132K | -13,200 | Closed |
|
|
GCL
9
Glazer Capital LLC
New York
| – | -$10K | -1,000 | Closed |
|
10
UBS Group
Zurich,
Switzerland
| – | -$5.98K | -600 | Closed |
|
IBER.U Hedge Fund Activity: Q1 2023 in Review
0 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) for Q1 2023, worth a combined $0 — down 100% from $4.01M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of IBER.U and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Schechter Investment Advisors, exiting entirely with an estimated $1.75M sold.
- 0 institutional investors held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) as of Q1 2023, down from 10 in Q4 2022.
- Funds reported $0 of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant positions in Q1 2023 and 10 closed out, a net change of -10 holders.
- The largest Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant seller in Q1 2023 was Schechter Investment Advisors, an estimated $1.75M sold.
Based on aggregated 13F filings for Q1 2023.